According to the American Cancer Society, screening should continue as long as a woman is "in good health and is expected to live at least 10 more years." Omofoye says she follows guidance that women can get screened as long as they're healthy enough to be treated for breast cancer. ...
Describes the national mammography screening program in the Netherlands. Arguments of critics against the program; Issue on the cost effectiveness of the program; Screening quality.B. KuskaOxford University Press (OUP)JNCI: Journal of the National Cancer Institute...
The pros and cons of breast cancer screening are different for every woman. Age is an important factor. Even though the general recommendation is to start screening at 50 years of age, for women at higher risk (such as those who have breast cancer in their family), it may be a good id...
Furthermore, there is no convincing analysis showing that there is a beneficial impact of screening onoverallmortality.Breast cancer screeningis of course designed to have a specific impact on breast cancer mortality. However, this endpoint in itself may bias estimates of the effect of screening (...
Clearly these other bodies have found the data compelling enough to offer screening, so how is it that the Task Force can be the lone voice finding that the harms outweigh the benefits? We believe the new breast cancer recommendations are misguided, and should be viewed as a cautionary tale ...
Screening should continue if a woman is in good health and is expected to live at least 10 more years. All women should understand what to expect when getting a mammogram for breast cancer screening – what the test can and cannot do. ...
Obese women may be disadvantaged at diagnosis; they may have larger primary tumours, more positive lymph nodes, and more advanced stage [18], and they may be less likely to be diagnosed by screening [19]. The association between BMI and breast cancer outcome may vary in women of different ...
Among 28 deceased patients, 9 died of causes unrelated to breast cancer. The 5-year survival of Group I was 95% (72/76). Among this group of patients, 84% (64/76) had negative lymph nodes. At 5 to 10 years follow-up, there have been no breast cancer-related deaths among this ...
Screening for breast cancer: time, travel, and out-of-pocket expenses. We estimated the personal costs to women found to have a breast problem (either breast cancer or benign breast disease) in terms of time spent, miles trave... R H,Secker-Walker,P M,... - 《Journal of the National...